IndraLab

Statements

USP15 activates oncogenic capacity patient-derived glioma-initiating cells owing TGFbeta signalling. 1 / 1

| 1

eidos

"Depletion of USP15 reduces the oncogenic capacity of patient-derived glioma-initiating cells owing to diminished TGFbeta signalling , suggesting therapeutic potential for development of USP15 inhibitors ."

28959952

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP15 activates oncogenic capacity patient-derived glioma-initiating cells owing TGFbeta signalling. 1 / 1

INDRA sources:

Databases

Reading